Kanpi Duo

Indapamide and Candesartan cilexetil, the active ingredient in Kanpi Duo, is a combination antihypertensive presented as a tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Kanpi Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kanpi Duo, a combination antihypertensive, is indicated for conditions related to elevated blood pressure.

- Hypertension: lowers systolic and diastolic pressure in adults with primary hypertension. - Essential hypertension: provides sustained blood pressure control in patients with essential hypertension. - High blood pressure: reduces cardiovascular risk associated with chronically elevated blood pressure.

Kanpi Duo may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: unusual tiredness or lack of energy. - Increased urination: due to the diuretic component. - Electrolyte imbalance: low potassium or sodium levels. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Hyperkalemia: elevated potassium that can affect heart rhythm. - Acute renal impairment: sudden decline in kidney function. - Allergic reactions: rash, itching, or swelling. - Pancreatitis: inflammation of the pancreas. - Blood dyscrasias: abnormal blood cell counts.

Before initiating therapy with Kanpi Duo, several safety considerations should be observed.

- Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Electrolyte assessment: check potassium and sodium levels regularly. - Renal function evaluation: monitor serum creatinine and eGFR. - Hepatic impairment caution: use with care in patients with severe liver disease. - Elderly patients: start at lower doses and watch for orthostatic symptoms. - Store at ambient temperature: keep in the original pack, protect from moisture.

Kanpi Duo can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): may cause additive renal effects. - Potassium‑sparing diuretics: increase risk of hyperkalemia. - ACE inhibitors: combined use can raise potassium levels excessively.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response and affect renal function. - Beta‑blockers: additive blood‑pressure lowering effect, monitor for hypotension.